In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1717 News Items found
Moriyina Cole, Financial Analyst, Hospital Operations, Laboratory Medicine
The Road Traveled: Moriyina Cole’s Path and the Women Who Brought Her Along

Moriyina Cole’s path to MSK started with a childhood in Sierra Leone, a move to Maryland when she was 15 years old, followed by time at Western Michigan University and Union Graduate College, where she received an undergraduate degree and a Master of Business Administration, respectively.
Visible Ink Performance
13 Years of Storytelling: MSK’s Visible Ink Writing Program Presents Performances of Works by Patients  

For more than a decade, Memorial Sloan Kettering Cancer Center’s (MSK) Visible Ink writing program has given a voice to more than 3,000 people with cancer, allowing each of them a unique opportunity to express themselves through interpretive dance, music, and poetry.
Man in his 70s (prostate cancer patient) smiling for camera
FDA Approves Promising Therapy for Advanced Prostate Cancer: Targets a Protein Called PSMA

A new treatment approved by the FDA could be a game changer for men with advanced prostate cancer.
Dr. Yelena Janjigian hugs MSK patient Cecilia Defoe
New Gastric & Esophageal Cancer Treatment Breakthrough

There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments.
Xiuzhen Chen (left), winner of the Kravis WiSE Postdoctoral Fellowship, and Brianna Naizir, winner of the Kravis WiSE Graduate Fellowship.
Two Sloan Kettering Institute Researchers Named 2022 Kravis Women in Science Endeavor (WiSE) Fellowship Grant Recipients

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that two Sloan Kettering Institute (SKI) researchers have been named 2022 Marie-Josée Kravis Women in Science Endeavor (Kravis WiSE) fellowship grant recipients.
Healthy foods
Watch: MSK Experts Share Tips for Healthy Eating and Explore the Connection Between Diet and Cancer

MSK recognized National Cancer Prevention Month (February) and National Nutrition Month (March) with online educational programming highlighting the connection between diet, nutrition, and cancer.
Dirk Remus and Richard Hite
SKI Scientists Determine Structure of a DNA Damage 'First Responder'

The results of this collaborative project overturn some conventional wisdom about how the DNA repair process works.
Q&A
Charles Swanton
Meet Charles Swanton, a Recipient of the Paul Marks Prize for Cancer Research

Charles Swanton of Cancer Research UK and University College London was one of the recipients of the 2021 Paul Marks Prize for Cancer Research.
Atefeh Riazi, Chief Information Officer
Atefeh Riazi Named 2022 Healthcare Information and Management Systems Society (HIMSS) Most Influential Women in Health IT Award Recipient

Atefeh “Atti” Riazi, Senior Vice President and Chief Information Officer of Memorial Sloan Kettering Cancer Center (MSK) has been selected as a recipient of the 2022 Health Information and Management System Society (HIMSS) Most Influential Women in Health IT Awards. 
Dr. Jae Park
How Do Gut Microbes Affect the Success of CAR T Immunotherapy? New Answers From MSK

In an effort to improve patients’ response to immunotherapy, MSK researchers have studied how microorganisms in the gut affect outcomes in people receiving CAR T therapy.